Stephen Schultz | Vice President of Investor Relations |
Justin Gover | Chief Executive Officer |
Darren Cline | U.S. Chief Commercial Officer |
Chris Tovey | Chief Operating Officer |
Volker Knappertz | Chief Medical Officer |
Scott Giacobello | Chief Financial Officer |
Phil Nadeau | Cowen and Company |
Salveen Richter | Goldman Sachs & Co. |
Ishmael Asante | Morgan Stanley |
Neena Bitritto-Garg | JP Morgan |
Marc Goodman | SVB Leerink |
Tazeen Ahmad | Bank of America Merrill Lynch |
Esther Rajavelu | Oppenheimer & Co. Inc. |
Paul Matteis | Stifel Financial Corp. |
Charles Duncan | Cantor Fitzgerald |
Derek Johnson | Guggenheim Partners |
Danielle Brill | Piper Jaffray |
Serge Belanger | Needham & Co. |
David Kideckel | AltaCorp Capital |
Greetings. Welcome to the GW Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.